Enhancing remyelination with CRISPR/Cas9 edited human oligodendrocyte precursor cells

被引:0
|
作者
Wagstaff, L. J. [1 ,2 ]
Fidanza, A. [1 ,2 ]
Franklin, R. J. M. [3 ]
Williams, A. C. [1 ,2 ]
机构
[1] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, MS Soc Edinburgh Ctr, Edinburgh, Midlothian, Scotland
[3] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust, MRC, Cambridge, England
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
T16-020B
引用
收藏
页码:E666 / E666
页数:1
相关论文
共 50 条
  • [41] CRISPR/CAS9 GENE EDITING
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27
  • [42] Cas9 Targeting and the CRISPR Revolution
    Barrangou, Rodolphe
    SCIENCE, 2014, 344 (6185) : 707 - 708
  • [44] Efficient Gene Disruption in Cultured Primary Human Endothelial Cells by CRISPR/Cas9
    Abrahimi, Parwiz
    Chang, William G.
    Kluger, Martin S.
    Qyang, Yibing
    Tellides, George
    Saltzman, W. Mark
    Pober, Jordan S.
    CIRCULATION RESEARCH, 2015, 117 (02) : 121 - 128
  • [45] Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells
    Zheng, Qiupeng
    Cai, Xiaohong
    Tan, Meng How
    Schaffert, Steven
    Arnold, Christopher P.
    Gong, Xue
    Chen, Chang-Zheng
    Huang, Shenglin
    BIOTECHNIQUES, 2014, 57 (03) : 115 - 124
  • [46] Multiplexed CRISPR gene editing in primary human islet cells with Cas9 ribonucleoprotein
    Bevacqua, Romina J.
    Zhao, Weichen
    Merheb, Emilio
    Kim, Seung Hyun
    Marson, Alexander
    Gloyn, Anna L.
    Kim, Seung K.
    ISCIENCE, 2024, 27 (01)
  • [47] MODELING AUTISM USING CRISPR/CAS9 AND HUMAN INDUCED PLURIPOTENT STEM CELLS
    Deneault, Eric
    Zaslaysky, Kirill
    Thompson, Tadeo
    Ellis, James
    Scherer, Stephen
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S161 - S161
  • [48] Editing of DNA methylation using CRISPR/Cas9 and a ssDNA template in human cells
    Katayama, Shota
    Andou, Masao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 581 : 20 - 24
  • [49] Using CRISPR/Cas9 to model human liver disease
    Alves-Bezerra, Michele
    Furey, Nika
    Johnson, Collin G.
    Bissig, Karl-Dimiter
    JHEP REPORTS, 2019, 1 (05) : 392 - 402
  • [50] CRISPR/Cas9 viral like particles for targeted genome editing in human cells
    Petris, G.
    Montagna, C.
    Casini, A.
    Maule, G.
    Zanella, I.
    Zacchigna, S.
    Zentilin, L.
    Giacca, M.
    Cereseto, A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A131 - A131